-
Markets Close The Week On Negative Note As Ukraine Worries Mount
Friday, August 15, 2014 - 5:01pm | 2461Read More...U.S. stocks erased early morning gains and finished lower following reports that Ukrainian artillery forces engaged armored vehicles entering Ukraine from Russia. Narayana Kocherlakota, Minneapolis Fed President, stated that labor strength in its current state appears to be far away from the...
-
Mid-Day Market Movers For Monday, June 16, 2014
Monday, June 16, 2014 - 12:52pm | 788Read More...Here are Monday's mid-day market movers. Gainers bluebird bio (NASDAQ: BLUE) - 33 percent - stocks surged after the biotech firm announced its gene therapy had success treating two patients with an inherited blood disorder called beta-thalassemia. Williams Companies (NYSE:...
-
Best Biotech Stocks of 2011
Tuesday, December 27, 2011 - 11:39am | 830Read More...Here's a quick look at nine of the best-performing biotech stocks of the past year. Achillion Pharmaceuticals (NASDAQ: ACHN) is up almost 88% year to date and about 37% higher just in the past month. This Connecticut-based biopharmaceutical company has three drugs in clinical trials to treat...
-
Brean Murray Initiates Achillion Pharmaceuticals At Buy, $9 PT
Friday, June 17, 2011 - 7:37am | 27Read More...Brean Murray Carret & Company has initiated coverage on Achillion Pharmaceuticals (NASDAQ: ACHN) with a Buy rating and $9 price target.
-
Oppenheimer Comments On 4Q10 Results For Achillion Pharmaceuticals
Thursday, March 3, 2011 - 9:07am | 156Read More...In a report published by Oppenheimer, Achillion Pharmaceuticals (NASDAQ: ACHN) reported 4Q10 results and the company will report the first ph.II data (28-day) for lead HCV candidate ACH-1625 in the next several weeks. Oppenheimer said that, based on antiviral activity in ph.Ib, it...
